|Description||PPTN, a 4,7-disubstituted 2-naphthoic acid derivative, is a high affinity and selective P2Y14 antagonist (KB = 434 pM) with >10,000-fold selectivity for P2Y14 over other P2Y receptors. PPTN blocks UDP-glucose–promoted chemotaxis of human neutrophils and does so across a concentration range consistent with its KB determined in the P2Y14-R–expressing cell line.|
|Purity||≥98% by HPLC|
|Synonyms||4-[4-(4-Piperidinyl)phenyl]-7-[4-(trifluoromethyl)phenyl]-2-naphthalenecarboxylic acid hydrochloride|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
Clopidogrel is converted to its active metabolite by cytochrome P450 (CYP) enzymes.
Regrelor is a P2Y12 antagonist. In Dec 2008, Phase-II for Thrombosis in USA was discontinued.
NF 546 is a P2Y11 agonist with pEC50 value of 6.27. It can stimulate release of interleukin-8 from human monocyte-derived dendritic cells.
MRS 2179 tetrasodium salt
MRS 2179 tetrasodium salt is a competitive antagonist at P2Y1 receptors (KB = 100 nM), which is selective over P2X1 (IC50 = 1.15 μM), P2X3 (IC50 = 12.9 μM), P2X...
Prasugrel is a platelet inhibitor (IC50=1.8 μM) , as a third-generation thienopyridine.
MRS 2957 triethylammonium salt
MRS 2957 triethylammonium salt 7 is a selective P2Y6 receptor agonists (EC50 = 12 nM) for the treatment of muscle wasting and neurodegeneration. It exhibits 14-...
The sodium salt of Suramin which is a P2 purinergic antagonist and has been also found to have the effect in blocking the G protein binds to GPCRs so that it wa...
INS-37217, also known as Denufosol, is a long- acting P2Y2 receptor agonist potentially for the treatment of cystic fibrosis. INS-37217 exhibits an EC50 of ~10 ...